Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Ensysce Biosciences Inc (NQ: ENSC )

0.3526 -0.0127 (-3.48%)
Streaming Delayed Price Updated: 9:39 AM EDT, Sep 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,164
Open 0.3700
Bid (Size) 0.3525 (10)
Ask (Size) 0.3554 (13)
Prev. Close 0.3653
Today's Range 0.3501 - 0.3700
52wk Range 0.3550 - 2.060
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Crude Oil Moves Higher; Dollar General Earnings Miss Estimates
Via Benzinga
Topics Earnings
Exposures Financial Fossil Fuels
Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings
Via Benzinga

Performance

YTD
-68.23%
-68.23%
1 Month
-17.39%
-17.39%
3 Month
-38.31%
-38.31%
6 Month
-56.14%
-56.14%
1 Year
-80.73%
-80.73%

More News

Read More
Ensysce Biosciences (ENSC) Stock Is Down 30% Today: What's Going On?
Via Benzinga
Dow Jumps Over 100 Points; Nvidia Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Ensysce Biosciences, Inc. Announces $5 Million Concurrent Registered Direct Offering and Exercise of Warrants
Via ACCESSWIRE
Ensysce Biosciences Announces IRB Approval for Key MPAR Study
Via ACCESSWIRE
Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
S&P 500 Edges Higher; American Woodmark Shares Slide
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Dips; Addex Therapeutics Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
US Stocks Mixed; ScanSource Reports Weak Q4 Results
Via Benzinga
Ensysce Biosciences Provides Key Themes Following IASP 2024 Symposium
Via ACCESSWIRE
Ensysce Biosciences Provides Mid-Year 2024 Update
Via ACCESSWIRE
Ensysce Biosciences Hosts IASP 2024 Symposium and Presents Clinical Dataset
Via ACCESSWIRE
Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting
Via ACCESSWIRE
ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Ensysce Biosciences Reports Second Quarter 2024 Financial Results
Via ACCESSWIRE
Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate
Via ACCESSWIRE
ENSC Stock Earnings: Ensysce Biosciences Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
Via ACCESSWIRE
Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Ensysce Biosciences Regains Compliance with Nasdaq
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.